Niowave

We manufacture radioisotopes to cure cancer and save lives. Niowave was founded in 2005 by former National Superconducting Cyclotron Laboratory researcher, Terry Grimm, and a group of private investors. Niowave is a worldwide leader in the research, development, manufacturing, and operation of superconducting electron linear accelerators which are used for medical radioisotope production. Niowave’s isotope production is unique due to the following core competencies:. Niowave is the only company in the world that can build and operate superconducting electron accelerators. Niowave operates an in-house radiochemistry facility to extract and purify solid, liquid, and gaseous radioactive isotopes. Niowave is a domestic supplier of medical and industrial radioisotopes from uranium and radium. Isotope production and distribution utilize existing radiopharmaceutical supply chain and FDA approval processes.